Moderna, manufacturer of one of the three main COVID-19 vaccines being circulated in the U.S., said Thursday it’s making new funding commitments to increase supply, which the company said will increase global supply of the vaccine to 3 billion doses by 2022.
Moderna commits funding to increase global supply of its COVID-19 vaccine
